Financial Health Assessment: ELDERBRIDGE LIMITED

1. Financial Health Score: B-

Explanation: Based on the available administrative and structural data, Elderbridge Limited exhibits a healthy corporate pulse with no signs of regulatory distress. However, the absence of detailed financial "blood work" (profit & loss, cash flow, and full balance sheet metrics) and the extremely low share capital require a cautious grade. The company's health is heavily reliant on the circulatory system of its parent company, meaning its standalone financial fitness cannot be fully verified without looking under the hood.

2. Key Vital Signs

• Corporate Pulse (Company Status): Strong. The company is Active and not in liquidation or administration. The patient is up and walking, showing no immediate signs of terminal financial distress.
• Regulatory Blood Pressure (Filing Compliance): Healthy. Accounts and confirmation statements are up to date, with the next accounts due by 31 December 2026. There is no regulatory hypertension; the company is breathing comfortably within its compliance deadlines.
• Genetic Makeup (Industry Classification): Sensitive. Operating under SIC code 64922 (Activities of mortgage finance companies), this patient has a genetic predisposition to macroeconomic fevers. Mortgage finance is highly sensitive to interest rate fluctuations and housing market temperatures.
• Organ Transplants (Ownership & Control): Dependent. Target Group Limited holds more than 75% of the voting rights. Elderbridge is effectively a subsidiary limb of a larger corporate body. This provides a strong safety net (parental immune system) but means the company is not standing on its own two feet.
• Blood Volume (Share Capital): Low. With only £375 in share capital, the company's base financial blood supply is incredibly low for a mortgage finance entity. This indicates the business relies on external transfusions—likely in the form of director or parent company loans—to fund its operations and asset purchases.
• Medical History (Previous Names & Officers): The company changed its name from Abbeynorth Limited shortly after incorporation in 2014, suggesting it was formed for a specific purpose or rebranding. There has been a recent change in the board (a director resignation in August 2026), which is akin to a minor organizational skin graft—normal for a subsidiary, but worth monitoring.

3. Diagnosis

The patient presents as a compliant, functioning subsidiary operating in a high-risk, high-leverage sector.

Administratively, Elderbridge Limited is in good health; its regulatory vitals are stable, and it is keeping up with its statutory hygiene (filings). However, from a strict financial anatomy perspective, the £375 share capital is a symptom of a leveraged financing model. In the mortgage finance sector, it is common for special purpose vehicles (SPVs) or subsidiaries to operate with nominal share capital, relying instead on vast intercompany loans from the parent to fund their lending activities.

Because the detailed financial statements (the full "blood panel") are not available in this dataset, we cannot definitively diagnose the state of the company's working capital, profitability, or liquidity. The recent director resignation could be a routine corporate reshuffle or a symptom of internal strategic changes. Ultimately, the company's financial wellness is deeply intertwined with the cardiovascular health of its parent, Target Group Limited.

4. Recommendations

To improve and ensure ongoing financial wellness, the following actions are recommended:

1. Conduct a Full Blood Panel: Request the full, filed accounts at Companies House to review the Profit & Loss reserves, net current assets, and overall debt levels. You must verify that the company’s liabilities are not quietly hemorrhaging cash, despite the healthy exterior.
2. Monitor the Parent's Health: Because Target Group Limited provides the lifeblood (voting control and presumably funding), any financial illness in the parent company will immediately infect Elderbridge. Regularly assess the financial statements of Target Group Limited.
3. Vaccinate Against Interest Rate Fevers: Given the mortgage finance sector's sensitivity to the Bank of England's base rate, ensure the company has robust hedging strategies in place to prevent margin compression if interest rates spike unexpectedly.
4. Review Capital Structure: While £375 is legally sufficient for a private limited company, consider whether injecting more share capital (equity) might be a healthier way to fund growth, rather than relying entirely on debt, which can cause financial cholesterol to build up in the balance sheet.